株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓マーカー検査装置:医療機器のパイプライン評価

Cardiac Markers Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 351354
出版日 ページ情報 英文 474 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.80円で換算しております。
Back to Top
心臓マーカー検査装置:医療機器のパイプライン評価 Cardiac Markers Diagnostic Tests - Medical Devices Pipeline Assessment, 2017
出版日: 2017年10月11日 ページ情報: 英文 474 Pages
概要

当レポートでは、心臓マーカー検査装置のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における最近の出来事などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • 心臓マーカー検査装置の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域 (国) 別
  • パイプライン製品:規制経路別
  • パイプライン製品:承認時期別 (推定)
  • 継続中の治験

第4章 心臓マーカー検査装置 - 開発中のパイプライン製品:企業別

  • 開発企業 - パイプライン製品:開発段階別
  • パイプライン製品:開発段階別

第5章 心臓マーカー検査装置の開発企業と製品の概要

  • 3PrimeDx, Inc.
  • Abbott Diagnostics
  • ACS Biomarker
  • Adaltis S.r.l.
  • AgPlus Diagnostics LTD
  • Alere Inc.
  • Alfa Scientific Designs, Inc.
  • Alfa Wassermann Diagnostic Technologies, LLC
  • Alfa Wassermann, Inc.
  • Amdix B.V.
  • Analyticon Biotechnologies AG
  • Applied Proteomics, Inc.
  • Arrayit Diagnostics, Inc.
  • Astute Medical, Inc.
  • Aterovax SA
  • Axela Inc.
  • AXO Science S.A.S.
  • Beckman Coulter, Inc.
  • BG Medicine, Inc.
  • Biocartis SA
  • Biomarker Design Forschungs GmbH
  • bioMerieux S.A.
  • BiOracle Limited
  • Bio-Rad Laboratories, Inc.
  • Biouniversa s.r.l.
  • CardioGenics Inc.
  • Cavadis B.V.
  • Cellgenex Diagnostics
  • Centice Corporation
  • Children's Hospital Boston
  • China Medical Technologies, Inc.
  • China Sky One Medical, Inc.
  • Cleveland HeartLab, Inc.
  • Co-Diagnostics HBDC, Inc.
  • CompanDX Ltd.
  • Corgenix Medical Corporation
  • Corgenix, Inc.
  • Coris BioConcept
  • Courtagen Life Sciences, Inc.
  • CPD, LLC
  • Critical Diagnostics
  • DestiNA Genomics Ltd
  • diaDexus, Inc. (Inactive)
  • Diagnoptics Technologies B.V.
  • DiaPat GmbH
  • ELITech Group
  • EnCare Biotech B.V.
  • Firalis SAS
  • Fundacio Clinic per a la Recerca Biomedica
  • Gamma Therapeutics, Inc.
  • GeneNews Limited
  • Genesis Detection Systems, Inc.
  • Global Genomics Group, LLC
  • Grifols, S.A.
  • Hannover Medical School
  • Hospices Civils de Lyon
  • IMMUNARRAY LTD.
  • Immunodiagnostic Systems Holdings plc
  • Infigo Diagnostics Ltd
  • infYnity biomarkers S.A.S.
  • Insilicos LLC
  • Institut National de la Sante et de la Recherche Medicale
  • iXensor Co. Ltd.
  • Kamiya Biomedical Company
  • KineMed, Inc.
  • King's College London
  • LipoScience, Inc.
  • Marshall University
  • Mayo Clinic.
  • Medical University of South Carolina
  • Mediomics, LLC
  • MedMira Inc.
  • MetaboGen AB
  • Metanomics Health GmbH
  • Mindray Medical International Limited
  • MMBiosensing, LLC
  • Nanosphere, Inc.
  • NorthShore University Health System
  • Nuclea Biotechnologies Inc.
  • One Drop Diagnostics
  • Oran Diagnostics, LLC
  • Oregon Health & Science University
  • Ortho-Clinical Diagnostics Inc.
  • Pacific Nanoscience, Inc.
  • Parque Cientifico de Madrid
  • Prevencio, LLC
  • Prognosys LLC
  • Pronota NV
  • Proof Centre of Excellence
  • Proplex Technologies, Llc
  • Proteome Sciences Plc
  • QLIDA Diagnostics
  • Quest Diagnostics Incorporated
  • Radiometer Medical ApS
  • Randox Laboratories Limited
  • Rheonix, Inc.
  • Rice University
  • RMIT University
  • Rna Diagnostics Inc.
  • Roche Diagnostics International Ltd.
  • ROS Technologies, Inc
  • Rosetta Genomics, Ltd.
  • SATT South East
  • Siemens Healthcare Diagnostics Inc.
  • Singulex, Inc.
  • Skyline Diagnostics BV
  • SomaLogic, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Tcoag Us Inc
  • Tethys Bioscience, Inc.
  • The Johns Hopkins University
  • The Pennsylvania State University
  • The University of Adelaide
  • The University of Tokyo
  • Thermo Fisher Scientific Inc.
  • ThreeFold Sensors (Inactive)
  • TissueNetix, Inc.
  • Toshiba Medical Systems Corporation
  • Tosoh Bioscience, Inc.
  • True Diagnostics, Inc.
  • Universite de Montreal
  • University College Dublin
  • University of California, San Diego
  • University of California, San Francisco
  • University of Colorado
  • University of Illinois
  • University of Nebraska
  • University of Oslo
  • University of Otago
  • University of Texas Medical Branch at Galveston
  • Vaiomer, SAS
  • Vanderbilt University
  • VEGA Ltd
  • Vermillion, Inc.
  • Vital Diagnostics, Inc.
  • Warnex Inc. (Inactive)
  • Washington University School of Medicine

第6章 心臓マーカー検査装置 - 最近の出来事

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0490EPD

GlobalData's Medical Devices sector report, "Cardiac Markers Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Cardiac Markers Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Markers Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Markers Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Markers Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 21

2 Introduction 22

  • 2.1 Cardiac Markers Diagnostic Tests Overview 22

3 Products under Development 23

  • 3.1 Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 23
  • 3.2 Cardiac Markers Diagnostic Tests - Pipeline Products by Segment 24
  • 3.3 Cardiac Markers Diagnostic Tests - Pipeline Products by Territory 25
  • 3.4 Cardiac Markers Diagnostic Tests - Pipeline Products by Regulatory Path 26
  • 3.5 Cardiac Markers Diagnostic Tests - Pipeline Products by Estimated Approval Date 27
  • 3.6 Cardiac Markers Diagnostic Tests - Ongoing Clinical Trials 28

4 Cardiac Markers Diagnostic Tests - Pipeline Products under Development by Companies 29

  • 4.1 Cardiac Markers Diagnostic Tests Companies - Pipeline Products by Stage of Development 29
  • 4.2 Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 34

5 Cardiac Markers Diagnostic Tests Companies and Product Overview 42

  • 5.1 1Drop Diagnostics Company Overview 42
  • 5.2 3PrimeDx, Inc. Company Overview 43
  • 5.3 A/C Diagnostics LLC Company Overview 44
  • 5.4 Abbott Diagnostics Company Overview 45
  • 5.5 ACS Biomarker Company Overview 57
  • 5.6 Adaltis S.r.l. Company Overview 58
  • 5.7 AgPlus Diagnostics LTD Company Overview 60
  • 5.8 Akrivis Technologies LLC Company Overview 61
  • 5.9 Alere Inc Company Overview 62
  • 5.10 Alfa Scientific Designs Inc Company Overview 63
  • 5.11 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 64
  • 5.12 Applied Proteomics Inc Company Overview 66
  • 5.13 Arrayit Diagnostics, Inc. Company Overview 68
  • 5.14 Astute Medical Inc Company Overview 69
  • 5.15 Aterovax SA Company Overview 70
  • 5.16 Axela Inc Company Overview 72
  • 5.17 AXO Science SAS Company Overview 73
  • 5.18 Beckman Coulter Inc Company Overview 76
  • 5.19 BG Medicine Inc Company Overview 80
  • 5.20 Biomarker Design Forschungs GmbH Company Overview 81
  • 5.21 bioMerieux S.A. Company Overview 82
  • 5.22 Bio-Rad Laboratories Inc Company Overview 84
  • 5.23 Biouniversa srl Company Overview 85
  • 5.24 Boditech Med Inc Company Overview 86
  • 5.25 British Heart Foundation Company Overview 87
  • 5.26 CardiNor AS Company Overview 88
  • 5.27 Cavadis BV Company Overview 89
  • 5.28 Cellgenex Diagnostics Company Overview 93
  • 5.29 Children's Hospital Boston Company Overview 94
  • 5.30 China Medical Technologies Inc (Inactive) Company Overview 95
  • 5.31 China Sky One Medical Inc Company Overview 101
  • 5.32 Co-Diagnostics HBDC, Inc. Company Overview 102
  • 5.33 CompanDX Ltd. Company Overview 103
  • 5.34 Corgenix Medical Corp Company Overview 104
  • 5.35 Coris BioConcept Company Overview 108
  • 5.36 CPD, LLC Company Overview 109
  • 5.37 Critical Diagnostics Company Overview 110
  • 5.38 DestiNA Genomics Ltd Company Overview 112
  • 5.39 Diagnos Inc Company Overview 113
  • 5.40 Diazyme Laboratories Inc Company Overview 114
  • 5.41 ELITechGroup Inc Company Overview 117
  • 5.42 EMD Millipore Corp Company Overview 120
  • 5.43 Emory University Company Overview 121
  • 5.44 Firalis SAS Company Overview 122
  • 5.45 French National Institute of Health and Medical Research Company Overview 125
  • 5.46 Fujirebio Diagnostics Inc Company Overview 127
  • 5.47 Fundacio Clinic per a la Recerca Biomedica Company Overview 129
  • 5.48 GeneNews Ltd Company Overview 130
  • 5.49 Genesis Detection Systems, Inc. Company Overview 133
  • 5.50 Global Genomics Group LLC Company Overview 135
  • 5.51 Grifols SA Company Overview 138
  • 5.52 Hannover Medical School Company Overview 139
  • 5.53 HealthCheck Diagonstics Inc Company Overview 141
  • 5.54 Infigo Diagnostics Ltd (Inactive) Company Overview 142
  • 5.55 infYnity biomarkers S.A.S. Company Overview 143
  • 5.56 Insilicos LLC Company Overview 144
  • 5.57 iXensor Co. Ltd. Company Overview 145
  • 5.58 John Hopkins University Company Overview 146
  • 5.59 Kamiya Biomedical Company Company Overview 149
  • 5.60 KineMed Inc Company Overview 150
  • 5.61 King's College London Company Overview 151
  • 5.62 Laboratory Corp of America Holdings Company Overview 153
  • 5.63 Magnisense SAS Company Overview 154
  • 5.64 Mayo Clinic US Company Overview 155
  • 5.65 MDNA Life Sciences Inc Company Overview 156
  • 5.66 Medical University of South Carolina Company Overview 157
  • 5.67 Mediomics, LLC Company Overview 159
  • 5.68 MedMira Inc. Company Overview 160
  • 5.69 MetaboGen AB Company Overview 161
  • 5.70 Metanomics Health GmbH Company Overview 162
  • 5.71 Mindray Medical International Ltd Company Overview 164
  • 5.72 MMBiosensing, LLC Company Overview 167
  • 5.73 MyCartis NV Company Overview 168
  • 5.74 MyHealthTest Pty Ltd Company Overview 171
  • 5.75 Nanosphere Inc Company Overview 172
  • 5.76 Nirmidas Biotech Inc Company Overview 174
  • 5.77 NorthShore University Health System Company Overview 175
  • 5.78 Nuclea Biotechnologies Inc. (Inactive) Company Overview 176
  • 5.79 Numares AG Company Overview 177
  • 5.80 Oran Diagnostics LLC Company Overview 178
  • 5.81 Orangelife Company Overview 179
  • 5.82 Oregon Health & Science University Company Overview 183
  • 5.83 Ortho-Clinical Diagnostics Inc Company Overview 184
  • 5.84 Oxford Impedance Diagnostics Ltd Company Overview 187
  • 5.85 Parque Cientifico de Madrid Company Overview 188
  • 5.86 Prevencio Inc Company Overview 189
  • 5.87 Prognosys LLC Company Overview 191
  • 5.88 Proplex Technologies Llc Company Overview 192
  • 5.89 Proteome Sciences Plc Company Overview 193
  • 5.90 QLIDA Diagnostics Company Overview 194
  • 5.91 Radiometer Medical ApS Company Overview 195
  • 5.92 Randox Laboratories Ltd Company Overview 198
  • 5.93 Rheonix Inc Company Overview 200
  • 5.94 Roche Diagnostics International Ltd Company Overview 201
  • 5.95 ROS Technologies, Inc Company Overview 207
  • 5.96 Rosetta Genomics Ltd Company Overview 208
  • 5.97 Siemens Healthcare GmbH Company Overview 209
  • 5.98 Singulex Inc Company Overview 222
  • 5.99 SomaLogic Inc Company Overview 225
  • 5.100 SpinChip Diagnostics AS Company Overview 227
  • 5.101 SPIROCOR Ltd. Company Overview 229
  • 5.102 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 230
  • 5.103 T2 Biosystems Inc Company Overview 231
  • 5.104 Tcoag Us Inc Company Overview 232
  • 5.105 Tethys Bioscience Inc (Inactive) Company Overview 233
  • 5.106 The Binding Site Group Ltd Company Overview 234
  • 5.107 The Pennsylvania State University Company Overview 236
  • 5.108 The University of Adelaide Company Overview 237
  • 5.109 Thermo Fisher Scientific Inc Company Overview 238
  • 5.110 ThreeFold Sensors (Inactive) Company Overview 240
  • 5.111 TissueNetix Inc Company Overview 241
  • 5.112 Toshiba Medical Systems Corporation Company Overview 242
  • 5.113 Tosoh Bioscience Inc Company Overview 243
  • 5.114 True Diagnostics Inc Company Overview 245
  • 5.115 University College Dublin Company Overview 246
  • 5.116 University Hospital of Lyon Company Overview 247
  • 5.117 University of Arizona Company Overview 248
  • 5.118 University of California San Diego Company Overview 249
  • 5.119 University of California San Francisco Company Overview 250
  • 5.120 University of Colorado Company Overview 251
  • 5.121 University of Illinois Company Overview 252
  • 5.122 University of Montreal Company Overview 253
  • 5.123 University of Nebraska Company Overview 254
  • 5.124 University of Nice Sophia Antipolis Company Overview 255
  • 5.125 University of Oslo Company Overview 256
  • 5.126 University of Otago Company Overview 258
  • 5.127 University of Saskatchewan Company Overview 259
  • 5.128 University of Texas Medical Branch at Galveston Company Overview 260
  • 5.129 University of Texas Southwestern Medical Center Company Overview 261
  • 5.130 University of Tokyo Company Overview 262
  • 5.131 University of Vermont Company Overview 263
  • 5.132 Upstream Medical Technologies Ltd Company Overview 264
  • 5.133 Vaiomer SAS Company Overview 266
  • 5.134 vall d hebron institut de Recerca Company Overview 268
  • 5.135 VEGA Ltd Company Overview 269
  • 5.136 Vermillion Inc Company Overview 270
  • 5.137 Washington University School of Medicine Company Overview 271

6 Cardiac Markers Diagnostic Tests - Recent Developments 272

  • 6.1 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma 272
  • 6.2 Sep 08, 2017: Singulex Receives New, Broad Patent for Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out 272
  • 6.3 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 273
  • 6.4 Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses 273
  • 6.5 Aug 30, 2017: bioMerieux - First-Half 2017 Results 274
  • 6.6 Aug 15, 2017: T2 Biosystems and Aridis Pharmaceuticals Join Antimicrobials Working Group 277
  • 6.7 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 278
  • 6.8 Aug 10, 2017: Beckman Coulter Diagnostics Announces Enhancements to the Access 2 Immunoassay System 279
  • 6.9 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 279
  • 6.10 Aug 03, 2017: Siemens extends appointment of CEO Joe Kaeser 280
  • 6.11 Aug 03, 2017: Siemens: Earnings Release Q3 FY 2017 280
  • 6.12 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 282
  • 6.13 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 283
  • 6.14 Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 284
  • 6.15 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 285
  • 6.16 Aug 01, 2017: Evaluations of the Analytical Performance of the Singulex Cardiac Troponin I Assay Used on its Single Molecule Counting Technology Platform Demonstrates Ability to Improve Cardiovascular Disease Rule-Out 288
  • 6.17 Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results 289
  • 6.18 Aug 01, 2017: Proteome Sciences: Directorate changes 293
  • 6.19 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 294
  • 6.20 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 301
  • 6.21 Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 302
  • 6.22 Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 303
  • 6.23 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 303
  • 6.24 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 306
  • 6.25 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 308
  • 6.26 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 309
  • 6.27 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 311
  • 6.28 Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China 312

7 Appendix 469

  • 7.1 Methodology 469
  • 7.2 About GlobalData 472
  • 7.3 Contact Us 472
  • 7.4 Disclaimer 472

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 25
  • Table 2: Cardiac Markers Diagnostic Tests - Pipeline Products by Segment 26
  • Table 3: Cardiac Markers Diagnostic Tests - Pipeline Products by Territory 27
  • Table 4: Cardiac Markers Diagnostic Tests - Pipeline Products by Regulatory Path 28
  • Table 5: Cardiac Markers Diagnostic Tests - Pipeline Products by Estimated Approval Date 29
  • Table 6: Cardiac Markers Diagnostic Tests - Ongoing Clinical Trials 30
  • Table 7: Cardiac Markers Diagnostic Tests Companies - Pipeline Products by Stage of Development 31
  • Table 8: Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 36
  • Table 9: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 10: One Drop Diagnostic Device - Cardiovascular Disease - Product Status 44
  • Table 11: One Drop Diagnostic Device - Cardiovascular Disease - Product Description 44
  • Table 12: 3PrimeDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 13: PulsePredic Test - Product Status 45
  • Table 14: PulsePredic Test - Product Description 45
  • Table 15: A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 16: Methionine Enzymatic Assay - Product Status 46
  • Table 17: Methionine Enzymatic Assay - Product Description 46
  • Table 18: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 19: Alinity ci - Cardiac Diseases - Product Status 48
  • Table 20: Alinity ci - Cardiac Diseases - Product Description 48
  • Table 21: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Status 48
  • Table 22: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Description 49
  • Table 23: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Status 49
  • Table 24: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Description 49
  • Table 25: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Status 50
  • Table 26: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Description 50
  • Table 27: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status 50
  • Table 28: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description 51
  • Table 29: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status 51
  • Table 30: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description 51
  • Table 31: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status 52
  • Table 32: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description 52
  • Table 33: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Status 52
  • Table 34: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Description 53
  • Table 35: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status 53
  • Table 36: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description 53
  • Table 37: ARCHITECT ci4100 Integrated System - Galectin-3 Assay - Product Status 53
  • Table 38: ARCHITECT ci4100 Integrated System - Galectin-3 Assay - Product Description 54
  • Table 39: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Status 54
  • Table 40: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Description 54
  • Table 41: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status 55
  • Table 42: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description 55
  • Table 43: ARCHITECT ci8200 Integrated System - Galectin-3 Assay - Product Status 55
  • Table 44: ARCHITECT ci8200 Integrated System - Galectin-3 Assay - Product Description 55
  • Table 45: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Status 56
  • Table 46: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Description 56
  • Table 47: ARCHITECT i1000SR - NT Pro BNP Assay - Product Status 56
  • Table 48: ARCHITECT i1000SR - NT Pro BNP Assay - Product Description 57
  • Table 49: ARCHITECT i1000SR System - High Sensitive Troponin I Assay - Product Status 57
  • Table 50: ARCHITECT i1000SR System - High Sensitive Troponin I Assay - Product Description 57
  • Table 51: ARCHITECT i2000SR - NT Pro BNP Assay - Product Status 58
  • Table 52: ARCHITECT i2000SR - NT Pro BNP Assay - Product Description 58
  • Table 53: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Status 58
  • Table 54: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Description 58
  • Table 55: ACS Biomarker Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 56: Multi-marker Heart Failure Assay - Product Status 59
  • Table 57: Multi-marker Heart Failure Assay - Product Description 59
  • Table 58: Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 59: CLIAgen Cardiac Marker Assay - Product Status 60
  • Table 60: CLIAgen Cardiac Marker Assay - Product Description 60
  • Table 61: Diagnostic Assay - hs - CRP - Product Status 61
  • Table 62: Diagnostic Assay - hs - CRP - Product Description 61
  • Table 63: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 64: AgPlus Diagnostic System - Troponin I Assay - Product Status 62
  • Table 65: AgPlus Diagnostic System - Troponin I Assay - Product Description 62
  • Table 66: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 67: Z-TECT - cTnI Assay - Product Status 63
  • Table 68: Z-TECT - cTnI Assay - Product Description 63
  • Table 69: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 70: Galectin-3 Test - Triage Meter Pro - Product Status 64
  • Table 71: Galectin-3 Test - Triage Meter Pro - Product Description 64
  • Table 72: Alfa Scientific Designs Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 73: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Status 65
  • Table 74: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Description 65
  • Table 75: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 76: ACE Axcel System - Apo A1 Assay - Product Status 66
  • Table 77: ACE Axcel System - Apo A1 Assay - Product Description 66
  • Table 78: ACE Axcel System - Apo B Assay - Product Status 67
  • Table 79: ACE Axcel System - Apo B Assay - Product Description 67
  • Table 80: ACE Axcel System - HsCRP Assay - Product Status 67
  • Table 81: ACE Axcel System - HsCRP Assay - Product Description 67
  • Table 82: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 83: API Diagnostic Test - Cardiovascular Disease - Product Status 68
  • Table 84: API Diagnostic Test - Cardiovascular Disease - Product Description 68
  • Table 85: SimpliPro Cardiac - Product Status 69
  • Table 86: SimpliPro Cardiac - Product Description 69
  • Table 87: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 88: Companion Diagnostic Test - Plavix - Product Status 70
  • Table 89: Companion Diagnostic Test - Plavix - Product Description 70
  • Table 90: Astute Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 91: Diagnostic Test - Acute Coronary Syndrome - Product Status 71
  • Table 92: Diagnostic Test - Acute Coronary Syndrome - Product Description 71
  • Table 93: Aterovax SA Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 94: AteroDx Combo - Product Status 72
  • Table 95: AteroDx Combo - Product Description 72
  • Table 96: AteroDx ISO - Product Status 73
  • Table 97: AteroDx ISO - Product Description 73
  • Table 98: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Status 73
  • Table 99: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Description 73
  • Table 100: Axela Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 101: Cardiac Troponin Biomarker Kit - Product Status 74
  • Table 102: Cardiac Troponin Biomarker Kit - Product Description 74
  • Table 103: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 104: Multiplexed Detection - BNP - Product Status 75
  • Table 105: Multiplexed Detection - BNP - Product Description 75
  • Table 106: Multiplexed Detection - Myoglobin - Product Status 76
  • Table 107: Multiplexed Detection - Myoglobin - Product Description 76
  • Table 108: Multiplexed Detection - Troponin - Product Status 76
  • Table 109: Multiplexed Detection - Troponin - Product Description 77
  • Table 110: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 111: Access 2 Immunoassay System - hsTnI - Product Status 78
  • Table 112: Access 2 Immunoassay System - hsTnI - Product Description 78
  • Table 113: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Status 79
  • Table 114: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Description 79
  • Table 115: SYNCHRON Lxi 725 D-Dimer Assay - Product Status 79
  • Table 116: SYNCHRON Lxi 725 D-Dimer Assay - Product Description 80
  • Table 117: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Status 80
  • Table 118: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Description 80
  • Table 119: UniCel DxC 600i Synchron Access B2-Glycoprotein 1 Ab Assay - Product Status 81
  • Table 120: UniCel DxC 600i Synchron Access B2-Glycoprotein 1 Ab Assay - Product Description 81
  • Table 121: BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 122: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Status 82
  • Table 123: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Description 82
  • Table 124: Biomarker Design Forschungs GmbH Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 125: Diagnostic Test - Cardiovascular Diseases - Product Status 83
  • Table 126: Diagnostic Test - Cardiovascular Diseases - Product Description 83
  • Table 127: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 128: Magnotech System - Cardiovascular Disease Assay - Product Status 84
  • Table 129: Magnotech System - Cardiovascular Disease Assay - Product Description 84
  • Table 130: VIDAS CRP Assay - Product Status 85
  • Table 131: VIDAS CRP Assay - Product Description 85
  • Table 132: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 133: BioPlex 2200 - Cardiac Disease - Product Status 86
  • Table 134: BioPlex 2200 - Cardiac Disease - Product Description 86
  • Table 135: Biouniversa srl Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 136: BAG3 ELISA - Cardiovascular Disease - Product Status 87
  • Table 137: BAG3 ELISA - Cardiovascular Disease - Product Description 87
  • Table 138: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 139: AFIAS-6 Myoglobin Assay - Product Status 88
  • Table 140: AFIAS-6 Myoglobin Assay - Product Description 88
  • Table 141: British Heart Foundation Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 142: Diagnostic Blood Test - Heart Attack - Product Status 89
  • Table 143: Diagnostic Blood Test - Heart Attack - Product Description 89
  • Table 144: CardiNor AS Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 145: Secretoneurin Test - Product Status 90
  • Table 146: Secretoneurin Test - Product Description 90
  • Table 147: Cavadis BV Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 148: CAVARISK CAD - Product Status 91
  • Table 149: CAVARISK CAD - Product Description 91
  • Table 150: CAVARISK CVD - Product Status 92
  • Table 151: CAVARISK CVD - Product Description 92
  • Table 152: Prognostic Test - Myocardial Infarction - Product Status 92
  • Table 153: Prognostic Test - Myocardial Infarction - Product Description 93
  • Table 154: Prognostic Test - Peripheral Artery Disease - Product Status 93
  • Table 155: Prognostic Test - Peripheral Artery Disease - Product Description 93
  • Table 156: Prognostic Test - Stroke - Product Status 94
  • Table 157: Prognostic Test - Stroke - Product Description 94
  • Table 158: Cellgenex Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 159: CardioStent Test - Product Status 95
  • Table 160: CardioStent Test - Product Description 95
  • Table 161: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 162: Biomarker Panel - Cardiac Allograft Vasculopathy - Product Status 96
  • Table 163: Biomarker Panel - Cardiac Allograft Vasculopathy - Product Description 96
  • Table 164: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 165: Cardiac Diseases Reagent Test Kit - ECLIA Analyzer - Product Status 97
  • Table 166: Cardiac Diseases Reagent Test Kit - ECLIA Analyzer - Product Description 98
  • Table 167: Diagnostic Assay - C-Reactive Protein - Product Status 98

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Markers Diagnostic Tests - Pipeline Products by Stage of Development 25
  • Figure 2: Cardiac Markers Diagnostic Tests - Pipeline Products by Segment 26
  • Figure 3: Cardiac Markers Diagnostic Tests - Pipeline Products by Territory 27
  • Figure 4: Cardiac Markers Diagnostic Tests - Pipeline Products by Regulatory Path 28
  • Figure 5: Cardiac Markers Diagnostic Tests - Pipeline Products by Estimated Approval Date 29
  • Figure 6: Cardiac Markers Diagnostic Tests - Ongoing Clinical Trials 30
Back to Top